Literature DB >> 32546768

Immune status could determine efficacy of COVID-19 therapies.

Megan Cully.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32546768     DOI: 10.1038/d41573-020-00110-3

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum.

Authors:  Jill E Weatherhead; Eva Clark; Tiphanie P Vogel; Robert L Atmar; Prathit A Kulkarni
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 2.  Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review).

Authors:  Silvia Vivarelli; Luca Falzone; Francesco Torino; Giuseppa Scandurra; Giulia Russo; Roberto Bordonaro; Francesco Pappalardo; Demetrios A Spandidos; Giuseppina Raciti; Massimo Libra
Journal:  Int J Oncol       Date:  2020-12-14       Impact factor: 5.650

Review 3.  Cross-talk between immune system and microbiota in COVID-19.

Authors:  Shaghayegh Baradaran Ghavami; Mahsa Pourhamzeh; Maryam Farmani; Shahrbanoo Keshavarz Azizi Raftar; Shabnam Shahrokh; Anastasia Shpichka; Hamid Asadzadeh Aghdaei; Mojdeh Hakemi-Vala; Nikoo Hossein-Khannazer; Peter Timashev; Massoud Vosough
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-11-02       Impact factor: 4.095

4.  Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment.

Authors:  Zhaoyan Zhao; Yuchen Xiao; Lingqing Xu; Ye Liu; Guanmin Jiang; Wei Wang; Bin Li; Tianchuan Zhu; Qingqin Tan; Lantian Tang; Haibo Zhou; Xi Huang; Hong Shan
Journal:  ACS Appl Mater Interfaces       Date:  2021-04-30       Impact factor: 9.229

5.  STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Authors:  Robbert Boudewijns; Hendrik Jan Thibaut; Suzanne J F Kaptein; Rong Li; Valentijn Vergote; Laura Seldeslachts; Johan Van Weyenbergh; Carolien De Keyzer; Lindsey Bervoets; Sapna Sharma; Laurens Liesenborghs; Ji Ma; Sander Jansen; Dominique Van Looveren; Thomas Vercruysse; Xinyu Wang; Dirk Jochmans; Erik Martens; Kenny Roose; Dorien De Vlieger; Bert Schepens; Tina Van Buyten; Sofie Jacobs; Yanan Liu; Joan Martí-Carreras; Bert Vanmechelen; Tony Wawina-Bokalanga; Leen Delang; Joana Rocha-Pereira; Lotte Coelmont; Winston Chiu; Pieter Leyssen; Elisabeth Heylen; Dominique Schols; Lanjiao Wang; Lila Close; Jelle Matthijnssens; Marc Van Ranst; Veerle Compernolle; Georg Schramm; Koen Van Laere; Xavier Saelens; Nico Callewaert; Ghislain Opdenakker; Piet Maes; Birgit Weynand; Christopher Cawthorne; Greetje Vande Velde; Zhongde Wang; Johan Neyts; Kai Dallmeier
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.